JPRN-UMIN000009171招募中未知
Analysis of efficacy and safety of antiviral therapy with telaprevir, peginterferon and ribavirin for recurrent hepatitis C after liver transplantation - Triple therapy for posttransplant hepatitis C
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •without abilty to understand informed consent
研究者
相似试验
已完成
不适用
Analysis of efficacy and safety of antiviral therapy with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantatiohepatitis C after liver transplantationJPRN-UMIN000014583Kyoto University Hospital30
已完成
不适用
Analysis of efficacy and safety of antiviral therapy with daclatasvir and asunaprevir for hepatitis C after organ transplantation -Pilot Studyhepatitis C after transplantationJPRN-UMIN000016558Trasnplantation surgery, Hiroshima University Hospital20
招募中
不适用
Analysis of efficacy and safety of antiviral therapy with simeprevir, peginterferon and ribavirin for recurrent hepatitis C after liver transplantatiohepatitis C after liver transplantationJPRN-UMIN000012219Kyoto University Hospital30
招募中
3 期
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised control trialCTRI/2020/06/025575AIIMS Rishikesh
已完成
不适用
Assessment of indication and efficacy of anti-viral therapy based on mucosal PCR assay in active UC patients with CMV infection.lcerative colitisJPRN-UMIN000022588Department of Gastroenterology and Hepatology, Kyoto University Hospital120